We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves New Refractory Multiple Myeloma Treatment

News   Jul 08, 2019 | Original story from the US Food and Drug Administration (FDA)

 
FDA Approves New Refractory Multiple Myeloma Treatment

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Common Diabetes Drugs May Help Prevent Parkinson’s Disease, Large Study Finds

News

Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.

READ MORE

Alterations in Subcellular Traffic Increases Invasiveness of Radioresistant Cancer Cells

News

Scientists have revealed the molecular mechanism regulating the trafficking of lysosomes that increases the invasiveness of radioresistant cancer cells following radiotherapy.

READ MORE

Nanobiologic Approach Trains the Innate Immune System To Eliminate Tumor Cells

News

A novel type of cancer immunotherapy trains the innate immune system to help it eliminate cancer cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are partnered with a therapeutic component.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE